Private Capital Advisors, Inc. Relay Therapeutics, Inc. Transaction History
Private Capital Advisors, Inc.
- $803 Million
- Q2 2025
A detailed history of Private Capital Advisors, Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Private Capital Advisors, Inc. holds 441,739 shares of RLAY stock, worth $3.11 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
441,739
Previous 100,000
341.74%
Holding current value
$3.11 Million
Previous $262,000
483.21%
% of portfolio
0.19%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding RLAY
# of Institutions
213Shares Held
173MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$196 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$94.7 Million0.1% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$94 Million4.31% of portfolio
-
Casdin Capital, LLC New York, NY11.4MShares$80.2 Million5.53% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$74.2 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $846M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...